Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Everlong
AddedApr 14, 2024
UpdatedJul 4, 2026
Everlong

Everlong

Pre-Seed

Everlong helps people regain control of their health and nutrition by automatically verifying their insurance benefits and providing them personalized care from top-vetted telehealth dietitians for $0 out-of-pocket.

Overview
Compare
Fundraising
Website

Everlong, founded with the mission to democratize access to personalized nutrition, offers telehealth dietitian services across the United States. Their core vision is to empower individuals to achieve optimal health through tailored dietary guidance. Everlong provides virtual consultations with registered dietitians, addressing a wide range of health concerns such as weight management and general health. The company emphasizes convenience and accessibility, allowing patients to book appointments quickly and ensuring coverage through major insurance providers.

Notable for its comprehensive approach to dietitian services, Everlong collaborates with experienced healthcare professionals to deliver high-quality care. The startup has achieved significant milestones, including broad insurance acceptance and a high percentage of patients receiving full coverage for their consultations. Everlong's impact is evident in its ability to make specialized nutritional advice accessible to a diverse population, contributing positively to public health outcomes.

Everlong - Similar Companies

Nourish logo

Nourish

usenourish.com

Longevo logo

Longevo

longevo.com

Prescribe Nutrition logo

Prescribe Nutrition

Culina Health logo

Culina Health

culinahealth.com

Newt logo

Newt

newtfit.com

Thrive Health Holdings logo

Thrive Health Holdings

Nourish logo

Nourish

nourish.com

Sylvan Health logo

Sylvan Health

sylvanhealth.com

Selvera logo

Selvera

selvera.com

Sirka logo

Sirka

sirka.io

BettrLife logo

BettrLife

RestoreHealth logo

RestoreHealth

restorehealth.com

EatRx logo

EatRx

Plantable logo

Plantable

plantable.com

Gyfs logo

Gyfs

eatlove.is

Everlong - Quick Facts

Who are Everlong's competitors?

Companies similar to Everlong include Nourish, Longevo, Prescribe Nutrition and Culina Health.

When was Everlong's last funding round?

Everlong's most recent funding round was for $20k (USD) in January 2024.

How much has Everlong raised to-date?

As of Jan 1, 2024, Everlong has raised a total of $20k (USD).

Everlong - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Nutrition Coaching
Tags
  • Healthtech